Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Sees Significant Drop in Short Interest
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC – Get Free Report) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 30,000 shares, a drop of 98.9% from the April 30th total of 2,700,000 shares. Currently, 0.3% of the shares of the company are short sold. Based […]
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC – Get Free Report) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 30,000 shares, a drop of 98.9% from the April 30th total of 2,700,000 shares. Currently, 0.3% of the shares of the company are short sold. Based […]
